EP1296710A4 - Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02) - Google Patents
Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02)Info
- Publication number
- EP1296710A4 EP1296710A4 EP00937165A EP00937165A EP1296710A4 EP 1296710 A4 EP1296710 A4 EP 1296710A4 EP 00937165 A EP00937165 A EP 00937165A EP 00937165 A EP00937165 A EP 00937165A EP 1296710 A4 EP1296710 A4 EP 1296710A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- disease virus
- vaccines against
- bursal disease
- infectious bursal
- against infectious
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
- C12N15/8258—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon for the production of oral vaccines (antigens) or immunoglobulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/517—Plant cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IL2000/000360 WO2001097839A1 (en) | 2000-06-19 | 2000-06-19 | Recombinant vaccines against infectious bursal disease virus |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1296710A1 EP1296710A1 (de) | 2003-04-02 |
EP1296710A4 true EP1296710A4 (de) | 2004-05-12 |
Family
ID=11042982
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00937165A Withdrawn EP1296710A4 (de) | 2000-06-19 | 2000-06-19 | Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02) |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1296710A4 (de) |
AU (1) | AU2000252449A1 (de) |
WO (1) | WO2001097839A1 (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6368602B1 (en) * | 2000-06-16 | 2002-04-09 | Hadasit Medical Research Services And Development Ltd | Mucosal immunization against hepatitis A virus (HAV) through rectal administration of HAV vaccine |
ES2307346B1 (es) * | 2004-01-21 | 2009-11-13 | Consejo Sup. Investig. Cientificas | Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones. |
ES2310062B1 (es) | 2005-07-15 | 2009-11-13 | Bionostra, S.L. | Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones. |
CN112442131B (zh) * | 2019-08-28 | 2022-08-12 | 中国农业科学院生物技术研究所 | 基于自组装铁蛋白纳米抗原颗粒及由其制备的传染性法氏囊病疫苗和应用 |
WO2023227599A1 (en) | 2022-05-23 | 2023-11-30 | Atlantic Technological University | Antimicrobial coating composition |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054126A (en) * | 1985-05-30 | 2000-04-25 | Commonwealth Scientific And Industrial Research Organization | Cloning and expression of host-protective immunogens of IBDV |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4956282A (en) * | 1985-07-29 | 1990-09-11 | Calgene, Inc. | Mammalian peptide expression in plant cells |
US5641490A (en) * | 1991-03-07 | 1997-06-24 | Virogenetics Corporation | Infectious bursal disease virus recombinant poxvirus vaccine |
US5605792A (en) * | 1993-11-04 | 1997-02-25 | The Ohio State University Research Foundation | Infectious bursal disease virus VP2 fusion protein expressed by baculovirus, use as diagnostic |
US5788970A (en) * | 1994-03-29 | 1998-08-04 | The University Of Maryland College Park | Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon |
-
2000
- 2000-06-19 EP EP00937165A patent/EP1296710A4/de not_active Withdrawn
- 2000-06-19 WO PCT/IL2000/000360 patent/WO2001097839A1/en not_active Application Discontinuation
- 2000-06-19 AU AU2000252449A patent/AU2000252449A1/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6054126A (en) * | 1985-05-30 | 2000-04-25 | Commonwealth Scientific And Industrial Research Organization | Cloning and expression of host-protective immunogens of IBDV |
Non-Patent Citations (12)
Title |
---|
CICEK-M ET AL.: "Expression of soluble and catalytically active plant (monocot) beta-glucosidases in E. coli.", BIOTECHNOL BIOENG, vol. 63, no. 40, 20 May 1999 (1999-05-20), pages 392-400 * |
FERNÁNDEZ-ARIAS A ET AL: "Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles.", THE JOURNAL OF GENERAL VIROLOGY. ENGLAND MAY 1998, vol. 79 ( Pt 5), May 1998 (1998-05-01), pages 1047 - 1054, XP002269599, ISSN: 0022-1317 * |
FODOR I ET AL: "Induction of protective immunity in chickens immunised with plasmid DNA encoding infectious bursal disease virus antigens", ACTA VETERINARIA HUNGARICA, vol. 47, no. 4, 1999, pages 481 - 492, XP000907298, ISSN: 0236-6290 * |
JAGADISH-MN ET AL.: "Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide", JOURNAL OF VIROLOGY, vol. 62, no. 3, March 1988 (1988-03-01), pages 1084 - 1087, XP002269600 * |
JAGADISH-MN ET AL.: "Birnavirus precursor polyprotein is processed in Escherichia coli by its own virus-encoded polypeptide.", J VIROL., vol. 62, no. 3, March 1988 (1988-03-01), pages 1084-1087 * |
KIBENGE F S B ET AL: "Formation of virus-like particles when the polyprotein gene (Segment A) of infectious bursal disease virus in expressed in insect cells", CANADIAN JOURNAL OF VETERINARY RESEARCH, vol. 63, no. 1, January 1999 (1999-01-01), pages 49 - 55, XP009025615, ISSN: 0830-9000 * |
MACREADIE I G ET AL: "PASSIVE PROTECTION AGAINST INFECTIOUS BURSAL DISEASE VIRUS BY VIRAL VP2 EXPRESSED IN YEAST", VACCINE, vol. 8, no. 6, 1990, pages 549 - 552, XP009026170, ISSN: 0264-410X * |
MASON-HS, TRANSGENIC PLANTS AS VACCINE PRODUCTION SYSTEMS, vol. 13, September 1995 (1995-09-01), pages 388-392 * |
See also references of WO0197839A1 * |
TACKET-CO ET AL., HUMAN IMMUNE RESPONSES TO A NOVEL NORWALK VIRSU VACCINE DELIVERED IN TRANSGENIC POTATOES, vol. 182, pages 302 - 305 * |
VAKHARIA V N ET AL: "Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins", VACCINE, vol. 12, no. 5, 1994, pages 452 - 456, XP009026169, ISSN: 0264-410X * |
WALMSLEY AMANDA M ET AL: "Plants for delivery of edible vaccines", CURRENT OPINION IN BIOTECHNOLOGY, vol. 11, no. 2, April 2000 (2000-04-01), pages 126 - 129, XP002269601, ISSN: 0958-1669 * |
Also Published As
Publication number | Publication date |
---|---|
EP1296710A1 (de) | 2003-04-02 |
WO2001097839A1 (en) | 2001-12-27 |
AU2000252449A1 (en) | 2002-01-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6217798A (en) | Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus | |
GB9811433D0 (en) | Virus vaccine | |
DE60219865D1 (de) | Auf Herpesvirus gegründeter rekombinanter Impfstoff gegen die infektiöse Bursalkrankheit | |
HUS1500047I1 (hu) | Rekombináns vakcina West Nile vírus ellen | |
EP1307130A4 (de) | Impfstoff gegen menschlichen immunschwächevirus | |
AU4932601A (en) | Recombinant parainfluenza virus expression systems and vaccines | |
IL147605A0 (en) | Mosaic infectious bursal disease virus vaccines | |
DE69839169D1 (de) | Aus infektiöser cDNA gewonnene rekombinate YF Viren-Impfstoffe | |
HUP0302265A3 (en) | A recombinant newcastle disease virus nucleoprotein mutant as a marker vaccine | |
IL158428A0 (en) | Vaccine composition comprising at least one hiv virus antigen | |
EP0597016A4 (en) | Infectious bursal disease virus recombinant poxvirus vaccine. | |
EP1399481A4 (de) | Rekombinante antikörper gegen infectious bursal disease virus (ibdv) | |
IL131212A0 (en) | Recombinant virus and live-virus vaccines | |
DK1372712T3 (da) | Vaccine mod equint herpesvirus | |
EP1389043A4 (de) | Impfstoff gegen das maul- und -klauensäure-virus | |
IL177903A (en) | Vaccine for Infectious Stock Disease Virus and its Use | |
EP1296710A4 (de) | Rekombinanter impfstoff gegen das für die bursal-krankheit verantwortliche virus(03.01.02) | |
DK1248650T3 (da) | Forbedrede DNA-vacciner til bovint herpesvirus 1 | |
HUP0202770A3 (en) | Human papilloma virus vaccine | |
PL372453A1 (en) | An infectious bursal disease virus variant | |
HUP0200560A2 (en) | Bhv-1 gene-deleted virus vaccine | |
AU5098700A (en) | Dna vaccine for protecting an avian against infectious bursal disease virus | |
IL179422A0 (en) | Recombinant vaccines against infectious bursal disease virus | |
IL136859A0 (en) | Recombinant vaccines against infectious bursal disease virus | |
HUP0102823A3 (en) | A broad spectrum infectious bursal disease virus vaccine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20030120 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: 7C 12N 15/82 B Ipc: 7C 12N 15/70 B Ipc: 7C 12N 7/04 B Ipc: 7C 07K 14/08 B Ipc: 7A 61K 39/12 A |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20040324 |
|
17Q | First examination report despatched |
Effective date: 20040702 |
|
17Q | First examination report despatched |
Effective date: 20040702 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20080404 |